Blog

Five Insights from RSNA 2024

Now that we’ve had time to reflect on RSNA 2024, we’ve collected insights our staff gleaned from their conversations at the show.

Flywheel Unveils New Viewer Updates at RSNA

Flywheel has made updates to its built-in viewer that address more of researchers’ key challenges when analyzing imaging data.

Behind the Software: Flywheel Engineer Profiles – Pablo Velasco, Senior Scientific Solutions Engineer

Pablo Velasco, Ph.D., applies a background in MRI and medical physics to solve data harmonization challenges. Learn how he helps clients scale cloud computation to save weeks of their time.

Behind the Software: Flywheel Engineer Profiles - Nicolas Pannetier, Director, Scientific Solutions Engineering

Nicolas directs our team of scientific solutions engineers, working with clients from academia to life sciences to come up with custom solutions to their greatest imaging challenges.

How trustworthy AI can fuel innovation in medicine

AI offers the opportunity to automate both routine imaging tasks and imaging analysis. How can you ensure you're developing trustworthy AI? Learn about the techniques and data practices that can help.

5 Insights on Leveraging AI and Imaging Data to Drive Oncology Research

AI-enhanced medical imaging in oncology can reveal deeper insights. Challenges include data variability and privacy concerns, but platforms like Flywheel help with data management, sharing & analysis.

Flywheel and Mint Medical Announce Collaboration to Expedite Research and Clinical Trial Workflows with Enhanced Oncology Imaging Solution

Flywheel announced its collaboration with Mint Medical, a medical technology company providing advanced software to foster data-driven radiology. This collaboration between Flywheel and Mint Medical

Voximetry Partners with Flywheel to Assure Confidence in Data Management, Security and Privacy for Clinical Dosimetry Services

This collaboration provides secure imaging de-ID, a data transfer platform and remote dosimetry services for nuclear medicine radiopharmaceutical therapy clinics.

Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research

Flywheel and the CAVATICA data analysis and sharing platform enable researchers and patients across the world to generate new insights into pediatric diseases and ensure more inclusive research.

Unlocking the Potential of Medical Imaging as Real-World Data

Genetic Engineering & Biotechnology News: Manage Data Better or Die

The growth of AI has raised expectations for good data management and data quality. Learn how to adapt to new standards of data tagging and medical imaging data integration.

Drug Discovery & Development: Opportunities and obstacles with ML and AI development

Is it counterproductive for drug developers to squander time and resources piecing together data management infrastructure for AI? Learn about data management realities that pose challenges to AI.

Streamlining Data Management for Precision Medicine at an Imaging Core

Learn how Flywheel streamlined data access at an imaging core studying cancer biomarkers and multimodal imaging.

Flywheel and the NIH Strategic Plan for Data Science

The NIH data management and sharing mandates are now in effect. Flywheel offers a complete, enterprise-scale solution for governance and compliance with DMS policies.

Drug Discovery & Development: Accelerating R&D with FAIR data

Five Key Takeaways from RSNA 2022

At RSNA 2022, Flywheel’s team saw many advancements in AI/ML, underscoring the need for advanced data management. Here are the trends we identified.

HIT Consultant: Transforming Healthcare with Medical Imaging AI

Read insights from our Chief Strategist, Travis Richardson, in HIT Consultant. Travis discusses how organizations need tools that help find, cleanse, and organize data to fuel AI breakthroughs.

Drug Discovery & Development: Fueling breakthroughs in pharma AI: 3 critical factors

Check out our article for Drug Discovery & Development calling on our experts' real-world experience with digital transformation and how pharma companies can be successful with AI.

Drug Discovery & Development: How federated learning can enable faster, more accurate pharmaceutical-grade AI

Flywheel CEO Jim Olson wrote for Drug Discovery & Development on the potential of federated learning for improving pharma AI.